PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
May 20, 2026American Journal of Respiratory and Critical Care Medicine

B72-34 Consider, Evaluate, and Treat for Pneumocystis Jirovecii Pneumonia Regardless of Presumed Immunocompetent Status

View Full Paper
Ask AI
Bookmark
Share

Authors

SAS AbbruzzeseASA Sutaria

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates the importance of prompt PJP evaluation in patients with severe hypoxia, indicating critical implications for diagnosis and treatment.

Key Points

  • The aim is to highlight the necessity of considering Pneumocystis jirovecii pneumonia (PJP) diagnosis in patients who may not appear immunocompromised.
  • Case analysis of a 58-year-old male with respiratory symptoms and imaging findings suggestive of PJP.
  • Evaluation included CT chest scans, fungal testing, and immunology workup.
  • Discussion of differential diagnoses and clinical management approach.
  • Patient showed a positive result for PJP following CT imaging indicating a cystic pattern and severe hypoxia.
  • Fungal testing indicated elevated levels, confirming PJP infection; elevated lactate dehydrogenase noted.
  • Immunodeficiency from HTLV-1 (322,000 copies/mL) was identified post-diagnosis, and treatment led to symptom resolution.

Cite This Study

Abbruzzese et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5114f03e14405aa9d65ahttps://doi.org/10.1093/ajrccm/aamag162.4323
View Full Paper
Ask AI
Bookmark
Share